Finally a trip to the top of the down channel. How exciting for OPGN holders yesterday as they finally felt the sting lessen. $4.43 is is the target price. Lets go!
OPGEN INC. OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
Do you think wave A is complete? I'm thinking of buying, should I wait for the bottom of the b wave? Or is this price affordable?
Thank you